![Andrew Saunders](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Saunders
Technik-/Wissenschafts-/F&E-Leiter bei
CAPTOR THERAPEUTICS SPOLKA AKCYJNA
Profil
Dr. Andrew Saunders, MD, is a Chief Medical Officer at Captor Therapeutics SA and a Chief Medical Officer at CellCentric Ltd. Dr. Saunders was previously employed as a Chief Medical Officer by Redx Pharma Plc, a Chief Medical Officer by Lytix Biopharma AS, a Chief Medical Officer by Bioenvision, Inc., and a Managing Director by Linden Oncology Ltd. He received his doctorate degree from Trinity College Dublin.
Aktive Positionen von Andrew Saunders
| Unternehmen | Position | Beginn |
|---|---|---|
| CAPTOR THERAPEUTICS SPOLKA AKCYJNA | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2024 |
CellCentric Ltd.
 CellCentric Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule inhibitors for cancer | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Andrew Saunders
| Unternehmen | Position | Ende |
|---|---|---|
| REDX PHARMA LTD | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2021 |
| LYTIX BIOPHARMA ASA | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2017 |
Bioenvision, Inc.
 Bioenvision, Inc. Medical/Nursing ServicesHealth Services Provides research and development services on pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 09.04.2007 |
Linden Oncology Ltd. | Vorstandsvorsitzender | - |
Ausbildung von Andrew Saunders
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
74
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Provides research and development services on pharmaceutical products | Health Services |
Trinity College Dublin
 Trinity College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CellCentric Ltd.
CellCentric Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule inhibitors for cancer | Health Technology |
Lytix Biopharma AS
 Lytix Biopharma AS Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops novel cancer immunotherapies | Health Technology |
Redx Pharma Plc
 Redx Pharma Plc Pharmaceuticals: MajorHealth Technology Discovers and develops novel, small molecule & targeted therapeutics for treatment of cancer and fibrotic disease | Health Technology |
Linden Oncology Ltd. | |
Captor Therapeutics SA
 Captor Therapeutics SA Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company which develops protein degradation drugs for cancer and autoimmune diseases | Health Technology |
